Skip to content

Early Detection of Myocardial Impairment and Prediction of Right Ventricular Hypertrophy in Patients with Connective Tissue Disease (EARLY-MYO-CTD)

Early Detection of Cardiac Impairment and Prediction of Right Ventricular Hypertrophy in Patients with Connective Tissue Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020667
Enrollment
Unknown
Registered
2019-01-12
Start date
2014-07-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Connective Tissue Disease

Interventions

Gold Standard:Multi-modality cardiac imaging
markers&#32
of&#32
and&#32
to&#32
investigate&#32
predictors&#32
RVH

Sponsors

Department Of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion Criteria for CTD with RVH: (1) Aged 18-80 years old; (2) Definite connective tissue diseases diagnosis; (3) Echocardiography demonstration (later confirmed by CMR) of a hypertrophic RV when maximal end-diastole RV wall thickness >4 mm due to CTD. 2.Inclusion Criteria for CTD without RVH: (1) Aged 18-80 years old; (2) Definite connective tissue diseases diagnosis; (3) Echocardiography demonstration (later confirmed by CMR) that maximal end-diastole RV wall thickness =4 mm. 3.Inclusion Criteria for Control group: (1) Absence of known systemic diseases; (2) Normal examinations; (3) Aged 18-80 years old; (4) Providing written informed consent.

Exclusion criteria

Exclusion criteria: 1. Documented coronary artery disease or prior angiography for coronary artery disease (>50% stenosis); 2. Patients with known congenital heart disease or other systemic diseases that might induce RVH; 3. Patients with standard metallic contraindications to CMR or an estimated glomerular filtration rate < 30 ml/min/1.73 m^2.

Design outcomes

Primary

MeasureTime frame
ECV;native T1;SPE, SEN, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactPu Jun

Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiaotong Universityo

pujun310@hotmail.com+86 13817577592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026